Mathias Lichterfeld, MD, PhD
Brigham and Women's Hospital/Massachusetts General Hospital · Massachusetts General Hospital · Ragon Institute of MGH, MIT and Harvard
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mathias Lichterfeld, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:38 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT03707977 · Dual bNAb Treatment in ChildrenNational Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infection · principal investigator
- Ph1/Ph2NCT02471430 · Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral TherapyMassachusetts General Hospital · completed · HIV Infection · principal investigator
- Ph2/Ph3NCT02369406 · Early Infant HIV Treatment in BotswanaHarvard School of Public Health (HSPH) · active not recruiting · HIV, Pediatric AIDS · principal investigator
- Ph1NCT00117429 · Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)Marcus Altfeld, M.D., Ph.D. · completed · HIV Infections
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.